Quick Take
Kalytera Therapeutics (KALTF) announced it has agreed to acquire a majority interest in Oregon 01 for $3.5 million.
Oregon 01 is doing business as ‘Clean Bi Design’ and will operate a hemp-based CBD extraction facility in Amity, Oregon.
Kalytera is developing CBD-based therapeutics, including for the prevention of Graft Versus Host Disease and the treatment of pain, uveitis as well as psoriasis, and intends to use Oregon 01’s operations to supply the company’s CBD needs.
Target Company
Amity, Oregon-based Clean Bi Design was founded to develop a hemp-based CBD extraction facility